Novocure Ltd buy melinda
Start price
06.03.18
/
50%
€19.62
Target price
17.04.18
€21.29
Performance (%)
8.85%
End price
17.04.18
€21.35
Summary
This prediction ended on 17.04.18 with a price of €21.35. The BUY prediction by melinda finished with a performance of 8.85%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novocure Ltd | 1.176% | 1.176% | -72.334% | -86.108% |
iShares Core DAX® | -0.654% | 1.989% | 14.984% | 18.052% |
iShares Nasdaq 100 | 0.903% | 5.664% | 36.140% | 58.351% |
iShares Nikkei 225® | -0.740% | -1.363% | 10.792% | 6.321% |
iShares S&P 500 | -0.013% | 3.020% | 28.126% | 48.476% |
Comments by melinda for this prediction
In the thread Novocure Ltd diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/05 Ergebnisse Veröffentlichung
$ 21.75
+0,15 (+ 0,69%) Tumor Behandlung Fields (TTFields) - PANOVA 3 Bauchspeicheldrüsenkrebs
Phase 3 2022 2022.12.31 Phase-3-Daten im Jahr 2022 fällig.
(Zielkurs erreicht)